Knowledge Center
Practical guides for formulators and procurement managers: ingredient comparisons, quality verification, regulatory updates.
Formulating with glucosyl hesperidin? Compare solubility, composition, clarity, taste, and batch documentation before choosing a citrus-flavonoid ingredient.
Read article →
A practical NR gummy decision guide: compare NRC and NRHM by raw-material taste, NR-equivalent dose, humidity control, packaging, and stability testing.
Read article →
Selling NMN, NR or NAD+ in Australia? Compare TGA listing conditions, NRC food-use permissions and the questions to resolve before sourcing ingredients.
Read article →
Learn how S-Equol differs from Equol, why gut microbiota matters, and which chemical and optical-purity data bulk buyers should verify.
Read article →
A procurement-focused guide to verifying a low-endotoxin NAD+ powder claim: lot-matched reports, test method, interference controls, packaging and the boundary between raw-material qualification and sterile-product release.
Read article →
A science-popularization and buyer guide explaining what SAC is, how it differs from allicin, aged garlic extract and S1PC, what research actually supports, and which COA and stability checks matter for bulk formulation.
Read article →A practical pre-purchase checklist for matching the actual batch, technical specification, safety information, packaging, and traceability documents before a bulk ingredient order.
Read article →
A formulation-focused guide to screen PDRN, GHK-Cu, and ceramide ingredients for serums, creams, masks, and other personal-care formats without turning preliminary science into finished-product claims.
Read article →A practical buyer guide to PQQ disodium identity, assay basis, lot COA review, light protection, microbial and elemental-impurity checks, and market-specific documentation.
Read article →How buyers should evaluate calcium L-5-methyltetrahydrofolate for capsule, tablet, powder and liquid development: exact form, assay basis, light/oxygen/heat controls and lot documentation.
Read article →A buyer-focused guide to sourcing spermidine trihydrochloride: confirm the salt form and assay basis, review the lot COA and handling data, compare samples to commercial lots, and plan moisture-controlled packaging.
Read article →
A practical guide to evaluating ≥99.5% NMN, batch-specific COAs, analytical methods, and supplier documentation before bulk purchase.
Read article →
A practical comparison of NR Chloride and NR Hydrogen Malate for capsules and tablets, covering salt form, NR-equivalent dosing, moisture, flow, compression, and stability.
Read article →A procurement checklist for NAD+ bulk material covering identity, assay, related substances, elemental impurities, residual solvents, microbiology, and batch COA.
Read article →A practical identity and specification checklist for buyers comparing citicoline and citicoline sodium in formulation projects.
Read article →A practical guide to reviewing USP and Ph. Eur. expectations, batch COA data, and method alignment when sourcing citicoline.
Read article →A process-focused overview of engineered-strain cultivation, enzymatic bioconversion, purification, crystallization, drying, and quality release for bulk citicoline.
Read article →A formulation-oriented guide to citicoline's water solubility, hygroscopicity, dosage forms, moisture control, and packaging decisions.
Read article →The difference between assay and purity in HPLC is the calculation and the question being answered. Review the method, reference standard, reporting basis and complementary tests before comparing supplier numbers.
Read article →S1PC is a stable, garlic-derived organosulfur amino acid formed during aged garlic extract processing — but organosulfur compounds as a class are notoriously easy to misquantify. Here's what separates a verifiable batch from an unverified one.
Read article →NMN and NR haven't cleared China's domestic food or pharmaceutical approval process, so they're classified and supplied as industrial/chemical raw materials for research, export, and other non-food, non-pharma uses. Here's what that status actually means for a buyer, and why a supplier stating it plainly is a good sign, not a red flag.
Read article →NMN, NAD+, NR, NRHM, NMNH, and NADH are often marketed as interchangeable "NAD+ precursors," but they differ in CAS identity, purity, salt form, and cost. This is a side-by-side decision guide for picking the right form for your formulation.
Read article →A one-off cheap order and a genuine long-term supplier relationship get evaluated on different criteria. This guide covers the concrete checks — batch consistency, certification verification, COA/MSDS accuracy, and capacity transparency — that separate the two.
Read article →A COA is only useful if you know how to read it — and "Not Detected" doesn't mean what most people assume it means. Here's a working guide to LOD/LOQ, lab accreditation, and the specific red flags that separate a real report from a rubber stamp.
Read article →For a small supplement or cosmetic brand, "which supplier do we pick" is really a question of which business model you want to run. Here's a framework covering MOQ, accountability, speed, and cost at different volume tiers, so the choice is deliberate rather than default.
Read article →A sample that matches the spec sheet on paper doesn't guarantee it will perform the same way in your warehouse or your formulation. This checklist covers the verification steps buyers should run before committing to a bulk order.
Read article →Cross-border sourcing of active ingredients fails less often at the factory and more often in customs — misclassified HS codes, incomplete paperwork, and unrealistic lead-time assumptions are where shipments actually get stuck.
Read article →"≥99% purity" and "≥99.5% purity" sound like a rounding difference, but that 0.5-percentage-point gap is made up of several distinct things — and whether it matters to your formulation depends entirely on what those things are, not on the headline number.
Read article →"Fermentation-derived" is often framed as a strictly better production route than chemical synthesis, but the real trade-offs — fewer steps and less solvent versus cost and scalability — depend heavily on the specific molecule, not on a universal rule.
Read article →Ordering raw powder is the easy part — turning it into a finished capsule on a shelf involves several process steps most first-time brand owners have never seen. Here's what actually happens at each stage.
Read article →The same ingredient name on two quotes doesn't mean the same product. Synthesis route, verified vs. claimed purity, testing documentation, and batch consistency all show up in price — and a suspiciously cheap quote is usually cutting one of them.
Read article →NADH stability is not proven by a day-one COA alone. Before approving bulk material, review the assay method, batch age, protected storage, shipment controls and a retest plan for the actual lot.
Read article →"Pomegranate-derived" sounds reassuring on a spec sheet, but urolithin A isn't actually present at meaningful levels in pomegranate fruit — it's a gut-bacteria metabolite that only a subset of people produce efficiently. Here's what that means for how commercial-grade material is actually made, and what to verify before you buy.
Read article →Dihydroberberine and berberine HCl are not interchangeable forms. Compare molecular form, formulation behavior, relevant batch data and the finished dosage form instead of treating either as a universal upgrade.
Read article →A copper peptide serum that discolors or loses efficacy after a few months on the shelf usually isn't a raw material defect — it's an unaddressed compatibility issue. Here's what actually destabilizes GHK-Cu, and a verification step most buyers skip entirely.
Read article →If your marketing team builds finished-product claims around a random blog post that overstates what PQQ does, you inherit that regulatory risk — not the blog. Here's what's actually substantiated about PQQ, sourced honestly, so you can market it defensibly.
Read article →NAD+ is the name every consumer recognizes, which is exactly why some brands default to it without asking whether the molecule itself makes formulation sense. Here's the real structural reason experts keep raising this question.
Read article →Of all the NAD+ precursors, NR has the most actively litigated patent history in the industry. If you're sourcing bulk nicotinamide riboside for a finished product, this is genuinely worth understanding before you sign a purchase order — not after.
Read article →"First-to-market" is a genuine selling point, but for a raw material buyer it also raises a fair question: is the supply chain behind this ingredient mature enough to support your production timeline? Here's an honest look at what makes NMNH different.
Read article →If you searched for NADP+ expecting the same market as NMN or NAD+, the buyer profile is actually quite different. Here's who typically sources this ingredient and what actually matters for their use case.
Read article →If you're used to working with NMN or NAD+ and expect the same shelf life from NADPH, plan again — this cofactor is the most perishable in the family, for structural reasons worth understanding before you set your own product's expiration date.
Read article →Catalog convenience groups FAD with NMN, NAD+, and NADH under "NAD+ precursors," but biochemically it belongs to a different vitamin family entirely. If you're formulating a combination product, this distinction actually matters.
Read article →If you've handled raw spermidine, you know the smell — and if you're building a capsule or tablet around it, that smell doesn't stay in the raw material bag. Here's the chemistry behind it and what actually works to manage it in a finished product.
Read article →If you're comparing fisetin quotes across suppliers and the purity numbers don't line up with the price, the assay method — not the material — is often the reason. Here's what's actually going on.
Read article →Ergothioneine's natural concentration in mushrooms is genuinely low, which creates a real supply-chain question worth asking before you scale a product around it: how was your specific batch actually produced?
Read article →Alpha-ketoglutarate's rise as a longevity ingredient has brought a wave of interest — and a real, easy-to-miss detail that affects how you calculate active dosage across different suppliers' products.
Read article →If you've only ever sourced DHEA for the US market, it's easy to assume it's a straightforward global dietary ingredient. It isn't — and finding that out after a shipment is held at customs is the wrong time to learn it.
Read article →If you've searched "ALA supplier" and gotten a mix of unrelated-looking results, you're not confused — the industry genuinely uses this abbreviation for two entirely different compounds. Here's how to make sure a purchase order actually gets you the ingredient you meant.
Read article →GABA is marketed heavily around calm and relaxation, which raises an obvious scientific question: as the brain's own inhibitory neurotransmitter, can an orally ingested dose actually get there? Here's an honest look.
Read article →The word "reduced" in reduced glutathione is doing real work — it's describing a chemical state that degrades under conditions many supply chains don't control for. Here's what actually protects it.
Read article →If you've read our post on why reduced glutathione oxidizes so readily, S-Acetyl-L-Glutathione is the direct answer to that problem — a deliberately engineered modification, not a naturally abundant compound. Here's how it actually works.
Read article →The MTHFR gene has become a genuine consumer talking point, driving demand for "active folate." Fewer buyers ask the more precise question: is the 5-MTHF you're sourcing actually the single active isomer, or a mixture?
Read article →If you're used to sourcing small-molecule ingredients with a straightforward HPLC purity percentage, nattokinase requires a different mental model entirely. Here's what actually determines whether a batch performs.
Read article →L-Carnosine is a legitimate, well-studied dipeptide — but if your target application is sports performance and muscle-level effects specifically, there's a pharmacokinetic detail worth understanding before you commit to a formulation strategy.
Read article →SAMe is one of the more chemically fragile ingredients we supply — the free molecule is barely stable enough to exist as bulk powder. Here's what buyers should know before comparing suppliers on "purity" alone.
Read article →"Vitamin B6" on a label is almost always shorthand for pyridoxine hydrochloride — a precursor form that still needs enzymatic conversion in the body. Here's the distinction worth understanding before choosing which form to formulate with.
Read article →"Ubiquinol" and "ubiquinone" are marketed as meaningfully different ingredients, and the underlying chemistry is real — but that same chemistry means a bag labeled ubiquinol can quietly convert toward ubiquinone if it isn't handled correctly.
Read article →If you've tried formulating a clear functional beverage or eye-care serum with native rutin, you've likely already run into its solubility ceiling. Here's the actual chemistry behind the glucosylated alternative.
Read article →Pterostilbene is frequently marketed as "better absorbed than resveratrol," and unlike some comparative claims in this category, this one has a specific, well-documented structural reason behind it worth actually explaining.
Read article →Sialic acid's connection to human milk oligosaccharides makes it a natural fit for infant nutrition positioning — but that same application involves processing conditions (high-heat sterilization) that this ingredient is genuinely sensitive to. Here's what to plan around.
Read article →Skincare formulators often shop for "ceramide" the way they'd shop for a small-molecule active with one fixed structure. The reality is closer to shopping for an oil blend — the ratio of components determines what you're actually formulating with.
Read article →PDRN sourcing conversations tend to focus on purity and origin. The number that actually determines whether a lot fits your application is one that gets less attention: molecular weight distribution.
Read article →"Natural biosurfactant" is doing a lot of marketing work for sophorolipid, but it glosses over a real functional variable: the same ingredient name covers materials that behave quite differently depending on congener ratio.
Read article →
More supplement brands are trading in-house manufacturing plans for CDMO partnerships. Here's the real workflow, what buyers now screen for, and why speed and flexibility are winning over pure cost.
Read article →
Complex synthesis, high costs, and low yields are a structural problem across active-ingredient manufacturing. PathGene's enzymatic and fermentation platform addresses the problem at the process level rather than optimizing around it.
Read article →Purity and quality control remain genuinely hard problems in synthetic-biology ingredient manufacturing; PathGene addresses them with Pfizer-trained quality engineering, patented synthesis routes, and dual USP/EP certification.
Read article →
Regulatory classification for NAD+ precursors and other novel actives keeps shifting across markets, and suppliers without complete documentation can leave buyers exposed at customs or during audits. Here's why this is genuinely hard, and how PathGene helps reduce that risk.
Read article →A market intelligence report on the NAD⁺ supplement landscape in 2025 — NMN regulatory update, NMN vs NR dynamics, emerging ingredients (NRHM, S-Equol, CDP-Choline stacks), and quality sourcing trends.
Read article →
Technical guide to NMN stability testing: degradation pathways, ICH Q1A protocol, packaging recommendations, and formulation-specific tips for capsule, tablet, powder, and liquid.
Read article →
A practical regulatory and logistics guide for procurement managers importing NMN, CDP-Choline, and other nutraceutical ingredients from China to US, EU, and APAC markets.
Read article →
What is NRHM (Nicotinamide Riboside Hydrogen Malate), how it differs from NR Chloride, its stability advantages, and formulation guidance.
Read article →A sourcing guide to S-Equol identity, engineered-microorganism bioconversion, chemical and optical purity, batch documentation, and formulation review.
Read article →
A technical comparison of CDP-Choline and Alpha-GPC for nootropic formulators — covering choline content, BBB penetration, clinical evidence, and cost.
Read article →
A practical due-diligence framework for procurement managers evaluating NMN and NAD⁺ raw material suppliers — beyond price and purity claims.
Read article →What to look for in an NMN COA, which analytical methods actually matter, and the red flags that signal a low-quality supplier.
Read article →A head-to-head technical comparison of NMN and NR for nutraceutical and pharmaceutical formulators — covering bioavailability, stability, purity targets, and regulatory status.
Read article →Scan to add WeChat
Alex Huang · Mon–Fri 9am–6pm CST
